Provectus Biopharmaceuticals Inc.

05/02/2024 | Press release | Distributed by Public on 05/02/2024 06:16

Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)